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Aim. To study the vitronectin exposure on the platelet surface in the presence of two forms of the plas-
minogen molecule: Lys- and Glu-plasminogens. Methods. Research was conducted on human platelets. 
Aggregometry was used to check the platelet vitality and cell response towards thrombin. To evaluate the 
infl uence of different plasminogen forms on the platelet vitronectin exposure we used the method of fl ow 
cytometry. Results. It was found that incubation of resting platelets with Lys-plasminogen increased the 
amount of vitronectin-positive cells, but did not affect signifi cantly their fl uorescent intensity. Thrombin 
stimulation led to an increase in both: the number of vitronectin-positive platelets and the signal of fl uo-
rescence at least by two times. The Lys-plasminogen adding to the suspension of washed platelets fol-
lowed by the thrombin stimulation enhanced the vitronectin exposure on the platelet surface and in-
creased the amount of vitronectin-positive cells as compared to the isolated thrombin stimulation. Glu-
plasminogen had no effect on the vitronectin exposure in case of resting or stimulated platelets. 
Conclusions. Lys-plasminogen but not its Glu-form enhances the exposure of vitronectin on the platelet 
surface. We suggest that the binding of Lys-plasminogen to the surface platelet receptors may generate 
plasmin that leads to the activation of intracellular signaling cascade.
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Introduction
The platelet activation and following thrombus for-
mation involve many adhesive proteins which are 
secreted from the platelet α-granules including fi -
brinogen, von Willebrand factor, fi bronectin and vit-
ronectin (Vn) [1]. However, it has been recently 
demonstrated that thrombus formation still occurs in 
the mice lacking both von Willebrand factor and fi -
brinogen [2] suggesting that other proteins such as 
fi bronectin, thrombospondin and Vn may be able to 
mediate the platelet adhesion and aggregation [3]. 
Among these proteins, a special attention has been 
paid to Vn, which plays a signifi cant role in platelet 
physiology. It may regulate thrombosis and fi brino-
lysis through the interaction with integrins, plas-
minogen activator inhibitor-1 (PAI-1), collagen, and 
the urokinase receptor. In plasma, this protein circu-
lates in an inactive folded form, in which most of its 
ligand-binding domains are hidden. Conversely, in 
the extracellular matrix and in blood platelets Vn is 
present in the activated multimeric form [4, 5]. It 
was suggested that this adhesive protein is a throm-
bus stabilizer as it has a site (Arg-Gly-Asp) with the 
potential for binding to integrins [6, 7]. However, the 
ideas about its exact role in thrombus formation are 
controversial. It was shown that the platelet-released 
Vn enhances the platelet aggregation, whereas the 
plasma Vn inhibits this process. It was reported that 
Vn has binding site to plasminogen, as monoclonal 
antibodies against the C-terminal portion of Vn in-
hibited plasminogen binding [8]. Recently we have 
shown that Lys-plasminogen but not its Glu-form in-
hibits the thrombin- and collagen-induced aggrega-
tion in the preparations of washed human platelets. 
In this study, we investigated the effects of two forms 
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of plasminogen on the vitronectin exposure on the 
surface of human platelets.
Materials and Methods
Human plasma and platelet preparations were obtai-
ned from blood of healthy volunteers (n = 5) as it was 
described before [9]. Research protocols were ap-
proved by the Ethical Committee of Palladin Insti-
tute of Biochemistry of NASU (from 3rd of Novem-
ber 2014, protocol N 10).
Aggregometry was used to check platelet vitality 
and cell response towards thrombin. Platelet aggrega-
tion was measured by optical aggregometry (aggre-
go meter «Solar AT-02», Belorussia). All assays were 
per formed within 60-180 minutes after platelet col-
lection. Experimental data were statistically analyzed 
using software «MS Excel» and «Agregometr 2.01». 
Thrombin (Sigma Aldrich, USA) at fi nal concentra-
tion 1 NIH unit/ml was used to stimulate platelets. 
Glu-plasminogen was purifi ed from fresh donor 
plasma and Lys-plasminogen was isolated from Cohn 
fraction II–III. Lysine-sepharose chromatography was 
used in both cases [10]. All preparations of plasmi-
nogen had no spontaneous plasmin activity. 
To evaluate the infl uence of different plasmino-
gen forms on Vn exposure by platelets the method 
of fl ow cytometry was used. The levels of exposed 
Vn were detected with use of respective antibodies 
to Vn (Sigma Aldrich, USA). The washed platelets 
(106 cells) were transferred into 100 μl of 20 mM 
HEPES buffer, pH 6.8 containing 137 mM NaCl, 
4mM KCl, 0.2 mM MgCl2, 0.2 % glucose and 0.2 % 
bovine serum albumin (BSA). To perform investi-
gations three groups of cells were used: resting 
platelets (control); platelets incubated with Glu- or 
Lys-plasminogen (ti me of exposure 3 min); plate-
lets treated with thro mbin (5min), and platelets 
treated with thrombin after their preliminary incu-
bation with Lys-plasminogen (3min). All proce-
dures with platelets were carried out at 22–25 C to 
avoid platelet hyperactivation. Platelets shortly 
thereafter incubation with plas minogen or resting 
platelets (control group) were treated with anti-Vn 
antibodies. To carry out immunochemical detection 
of Vn we prepared the mixture of antibodies in 
0.05 M sodium phosphate buffer (PBS), pH 7.4 
with 0.13 M NaCl and 1 % BSA. Antibodies to Vn 
(2 μg) we re mixed with 100μl of PBS and second-
ary FITC-conjugated antibodies (Sigma Aldrich, 
USA) (fi  nal dilution 1:100). The mixture was incu-
bated in the darkness at 4 C for 15 min. Platelets 
were incubated with the obtained mixture in the 
darkness at room temperature for 30 min. As a con-
trol of non-specifi c antibody binding we used plate-
lets which were incubated only with secondary 
FITC-conjugated antibodies. Non-bound antibod-
ies were removed by double washing in PBS by 
centrifugation at 3,000 g for 3 min at 20 C. The 
obtained suspension of washed platelets was resus-
pended in 1 ml of PBS and used for the investiga-
tion of Vn exposure at COULTER EPICS XL 
(Beckman Coulter, USA) equipped with argon la-
ser, excitation λ = 488nm. Evaluation of Vn expo-
sure on the platelet surface was done using two pa-
rameters: 1) percentage of Vn-positive platelets of 
the whole amount of investigated cells in the sam-
ple; 2) intensity of fl uorescence, which was moni-
tored by the channel FL1 (515–535 nm). To sort the 
Fig. 1. Effects of Lys- and Glu-plasminogen on vitronectin expo-
sure by intact and thrombin-stimulated platelets: 1 – resting plate-
lets, 2 – resting platelets incubated with Glu-plasminogen, 3 – 
resting platelets incubated with Lys-plasminogen, 4 – thrombin-
stimulated platelets, 5 – thrombin-stimulated platelets preliminary 
incubated with Glu-plasminogen, 6 – thrombin-stimulated platelets 
preliminary incubated with Lys-plasminogen. Blue columns – 
resting platelets, red columns – thrombin-stimulated platelets.
The concentrations of plasminogen forms and thrombin were 1.2 μM 
and 1.0 NIH units/ml respectively in all experiments. Difference 
in the compared groups is statistically signifi cant (р < 0.05): * – 
compared to the group of ‘resting platelets», # – compared to the 
group of «thrombin-stimulated platelets»
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platelets the corresponding gates were established. 
The chan ges in signal of fl uorescence, which were 
observed in case of the impact of the investigated 
molecules, were defi ned according to the displace-
ment of fl uorescence cur ves relative to the marker, 
which limits the fl u o rescence curve of the intact 
platelets. The quantitative changes of the fl uores-
cence were expressed in arbitrary units (AU) that 
mean the common logarithm according to scale 
Log FL1. To obtain statistically signifi cant results 
at least 10 thousand events were analyzed. 
The measurement of cytometric parameters in each 
group of cells was fulfi lled in two parallels. Then, a 
mean value for the corresponding data obtained from 
all donors was calculated. The results were graphi-
cally presented using «FCS Express V3» (De Novo 
Software, USA). The data were expressed as me-
an ± SD. Statistical treatment of the results was made 
with Student’s t-test, the difference was considered 
as signifi cant with p < 0.05.
Results and Discussion
Using the fl ow cytometric analysis we determined the 
amount of Vn-positive cells and their fl uorescence in-
tensity. The presented data characterize the vitro nectin 
exposure on the surface of resting and throm bin-
stimulated washed platelets (Fig. 1). The appearance 
of Vn-positive cells in the population of resting plate-
lets can be due to the spontaneous activation of a part 
of cells taken in the experiment. It is recommended to 
use the population of platelets, the level of spontane-
ous activation of which does not exceed 50–55 % [11] 
Fig. 2. Infl uence of Lys-plasminogen (А) and Glu-plasminogen (В) on vitronectin exposure by resting human platelets. Count – the 
amount of events, FL1 LOG – logarithm of fl uorescence intensity with FITC. Black colour-resting platelets, green colour-platelets 
incubated with Lys-plasminogen, blue colour-platelets incubated with Glu-plasminogen
Fig. 3. Infl uence of Lys-plasminogen (А) and Glu-plasminogen (В) on vitronectin exposure by stimulated human platelets. Count – the 
amount of events, FL1 LOG – logarithm of fl uorescence intensity with FITC. Black colour-resting platelets, blue colour-thrombin 
stimulated platelets, red colour-thrombin-stimulated platelets preliminary incubated with Lys-plaminogen (A) or Glu-plasminogen (B)
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that is in accordance with our data. When Lys-plas-
minogen was introduced into the incubation medium 
with intact platelets, an increase of vitronectin-posi-
tive cells was noted. The introduction of Glu-plas-
minogen had no effect (Fig. 1). It is known that the 
platelet affi nity for Lys-plasminogen is higher as com-
pared to Glu-plasminogen [12]. In its turn, the bound 
Lys-plasminogen may be considered as the preferable 
adhesive lygand for Vn, since the affi nity of Lys-plas-
minogen towards vitronectin is signifi cantly higher 
(Kd = 100 nM and Kd = 1 mM respectively) [8].
We established that thrombin activation caused an 
increase of Vn-positive cells at least by 2 times as 
compared to the population of resting platelets. It is 
known that thrombin activation leads to secretion of 
alpha-granules, which contain vitronectin. Accord-
ing to the previous data, the activated platelets se-
creted highly adhesive multimeric Vn, half of which 
remained the platelet bound [13]. If Lys-plasmino-
gen was added to the incubation medium prior to the 
thrombin activation, we noticed a signifi cant in-
crease of Vn-positive cells. In case of Glu-plasmino-
gen, signifi cant changes in the amount of Vn-positive 
cells were observed in comparison with the case of 
thrombin stimulation without prior plasminogen in-
cubation. This difference may be also explained by 
different affi nity of Glu- and Lys-plasminogens to-
wards vitronectin. 
The changes in intensity of the fl uorescence signal 
of intact and thrombin-activated platelets have the 
same tendency as it was demonstrated for the quantita-
tive rearrangement of the cells. The resting platelets 
incubated with Glu- or Lys-plasminogen do not reveal 
any signifi cant changes of the fl uorescence signal as 
compared to the control curve (Fig. 2). In case of the 
thrombin-activated platelets it was an essential shift of 
the peak of the fl uorescence curve to the right of the 
control curve (Fig. 3), which agrees with the appear-
ance of vitronectin-binding sites on the surface of 
thrombin-activated platelets. The preliminary incuba-
tion of stimulated platelets with Lys-plasminogen leads 
to the shift of the peak of fl uorescence to the right (Fig. 
3, A), whereas the incubation with Glu-plasminogen 
did not cause any changes as compared to the curve 
obtained for thrombin-stimulated platelets (Fig. 3, B).
The obtained results may be interesting consi-de-
ring the role of plasminogen in cellular signaling. As 
it has been recently shown on peripheral monocytes 
and macrophages, the plasminogen binding to the 
annexin A2 S100 A10 may induce the plasmin gen-
eration, which results in the activation of intracellu-
lar signaling cascade and leads to a pro-infl ammatory 
response [14]. It is quite pos-sible that the binding of 
Lys-plasminogen (which has open conformation and 
therefore is more readily converted into plasmin) to 
the platelet membrane may serve as an initial step of 
the cellular response. However, the further investi-
gations should be done to prove this suggestion.
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Lys-плазминоген стимулирует экспонирование
витронектина на поверхности тромбоцитов
Д. Д. Жерносеков, Я. М. Рока-Мойя,
А. А. Тихомиров, Т. В. Гриненко
Цель. Исследовать экспонирование витронектина на повер-
хности тромбоцитов в присутствии двух форм плазминоге-
на: Lys- и Glu-плазминогена. Методы. Исследования прово-
дили на тромбоцитах человека. Для проверки жизнеспособ-
ности тромбоцитов и клеточного ответа на тромбиновую 
стимуляцию использовали метод агрегометрии. Для оценки 
влияния разных форм плазминогена на экспонирование вит-
ронектина тромбоцитами использовали метод проточной ци-
тометрии. Результаты. Было показано, что инкубация ин-
тактных тромбоцитов с Lys-плазминогеном приводила к уве-
личению количества витронектин-позитивных клеток, но не 
оказывала существенного влияния на их интенсивность 
флю оресценции. Стимуляция тромбином сопровождалась 
по меньшей мере двукратным увеличением как числа вит-
ронектин-позитивных тромбоцитов, так и интенсивности 
сигнала флюоресценции. Добавление Lys-плазминогена к 
суспензии отмытых тромбоцитов с последующей активаци-
ей тромбином усиливало экспонирование витронектина на 
тромбоцитарной поверхности и увеличивало количество 
витронектин-позитивных клеток по сравнению с изолиро-
ванной стимуляцией агонистом. Glu-плазминоген не оказы-
вал влияния на экспонирование витронектина в случае ин-
тактных или активированных тромбоцитов. Выводы. Lys-
плазминоген, но не его Glu-форма, усиливает экспонирова-
ние витронектина на поверхности тромбоцитов. Мы пред-
полагаем, что связывание Lys-плазминогена с рецепторами 
на тромбоцитарной поверхности может способствовать об-
разованию плазмина, который, в свою очередь, запускает 
процессы внутриклеточного сигналинга.
Ключевые  слова: плазминоген, тромбоциты, тромбоци-
тарная секреция, витронектин, проточная цитометрия.
Lys-плазміноген стимулює експонування
вітронектину на поверхні тромбоцитів
Д. Д. Жерносєков, Я. М. Рока-Мойя,
А. О. Тихомиров, Т. В. Гриненко
Мета. Дослідити експонування вітронектину на поверхні 
тромбоцитів за присутності двох форм плазміногену: Lys- 
та Glu-плазміногену. Методи. Дослідження проводили на 
тромбоцитах людини. Для перевірки життєздатності клітин 
та клітинної відповіді на стимуляцію тромбіном використо-
вували метод агрегометрії. Для оцінки впливу різних форм 
плазміногену на експонування вітронектину тромбоцитами 
було використано метод протокової цитометрії. Результати. 
Було показано, що інкубація інтактних тромбоцитів з Lys-
плазміногеном призводила до зростання кількості віт ро нек-
тин-позитивних клітин, але суттєво не впливала на їх інтенсив-
ність флуоресценції. Стимуляція тромбіном супровод жу валася 
принаймні двократним зростанням як кількості віт ронектин-
позитивних тромбоцитів, так і інтенсивності сигналу флуорес-
ценції. Додавання Lys-плазміногену до суспензії відмитих 
тромбоцитів з наступною активацією тромбіном підсилюва-
ло експонування вітронектину на тромбоцитарній поверхні 
та збільшувало кількість вітронектин-позитивних клітин по-
рівняно з ізольованою стимуляцією агоністом. Glu-плаз мі-
ноген не спричиняв впливу на експонування вітронектину в 
разі інтактних та активованих тромбоцитів. Висновки. Lys-
плазміноген, але не його Glu-форма, підсилює експонування 
вітронектину на поверхні тромбоцитів. Ми припускаємо, що 
зв’язування Lys-плазміногену з рецепторами тромбоцитарної 
поверхні може сприяти утворенню плазміну, який, в свою 
чергу, запускає процеси внутрішньоклітинного сигналінгу.
Ключов і  слова: плазміноген, тромбоцити, тромбоцитар-
на секреція, вітронектин, протокова цитометрія.
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